[Are there significant differences between the two topical corticosteroids flunisolide (Inhacort) and budesonide (Pulmicort)?].
Sill
V
V
I. Medizinische Abteilung, Allgemeines Krankenhaus Wandsbek, Hamburg.
D000280:Administration, Inhalation; D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000009:adverse effects*; D019819:Budesonide; D002648:Child; D004305:Dose-Response Relationship, Drug; D005446:Fluocinolone Acetonide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D011282:Pregnenediones / Q000008:administration & dosage / Q000009:adverse effects*
D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D011282:Pregnenediones; D005446:Fluocinolone Acetonide; D019819:Budesonide; C007734:flunisolide
Gibt es signifikante Unterschiede zwischen den beiden topisch wirkenden Corticosteroiden Flunisolid (Inhacort) und Budesonid (Pulmicort)?